AUTONOMIC PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE
AUTONOMIC PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE
批准号:
6202532
负责人:
DAVID HERLIE ROBERTSON
金额:
$19.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2000-07-31
中文摘要
直立性不耐受是最常见的
自主神经功能障碍和许多残疾的原因。多达50万
美国人深受其害,但它是研究最少的疾病之一。
没有既定的治疗方法。其病因学知之甚少,但
假设是异质的。
在这个项目中,我们提出了一个潜在的机制,直立
不耐受,这可能代表了与
很大一部分或可能是大多数患者。我们
检验这些患者的亚组具有部分或
远端自主神经功能障碍,引起血液汇集的临床综合征,
盐浪费,血浆容量不足,尝试但不充分
的相对完整的近端自主神经支配的补偿
心
证明部分或远端自主神经功能障碍导致直立性
在某些患者中,必须满足几个标准。一是
必须是交感神经去甲肾上腺素能神经系统局部受损的证据
系统,而这一证据应基于生物化学,生理学
和药理学标准。第二,减值应大于
远端(下肢)部位比近端(心脏)部位更明显。第三、
应该保留中央自主控制。 最后,去神经
超敏反应应该是最大的地区,其中植物神经功能障碍是
最广泛的。
这一意想不到的发现,抑制血浆肾素水平发生在
这些患者,很大程度上与低血容量成正比,
尽管直立性心动过速和血浆去甲肾上腺素水平升高,
可能是导致血容量不足的关键损伤。以来
初步提交,我们有很多新的初步数据与我们的
假设(见图1、2、12、13和正文指定部分)。
这种疾病的成功机制特征应该导致
改善诊断和合理设计治疗,
出现先前无法解释的病理性
立位不耐受
英文摘要
Orthostatic intolerance is the most frequently encountered
dysautonomia and the cause of much disability. As many as 500,000
Americans are affected by it. Yet it is one of the least studied diseases.
There is no established therapy. Its etiology is poorly understood, but is
assumed to be heterogeneous.
In this project, we propose a potential mechanism for orthostatic
intolerance, which may represent the pathophysiology relevant to a
significant portion or perhaps a majority of this patient population. We
test the hypothesis that the subgroup of these patients have partial or
distal dysautonomia, giving rise to a clinical syndrome of blood pooling,
salt wasting, inadequate plasma volume, and attempted but inadequate
compensation of a relatively intact proximal autonomic innervation of the
heart.
To prove that a partial or distal dysautonomia causes orthostatic
intolerance in some patients, several criteria must be met. First, there
must be evidence of local impairment in the sympathetic noradrenergic
system, and this evidence should be based on biochemical, physiological
and pharmacological criteria. Second, the impairment should be greater at
distal (lower extremity) sites than at proximal (cardiac) sites. Third,
central autonomic control should be preserved. Finally, denervation
hypersensitivity should be greatest in the areas where the dysautonomia is
most extensive.
The unexpected finding that suppressed plasma renin levels occur in
these patients, largely in direct proportion to the hypovolemia, and, in
spite of orthostatic tachycardia and raised plasma norepinephrine levels,
could be the crucial impairment that results in the hypovolemia. Since the
initial submission, we have much new preliminary data congruent with our
hypothesis (see figures 1,2,12,13 and the designated sections of text.
Successful mechanistic characterization of this disorder should lead
to improved diagnosis and the rational design of therapy in a significant
portion of individuals presenting with previously unexplained pathological
orthostatic intolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADMINISTRATIVE CORE
-
批准号:8147954
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Echocardiograph and Vascular Doppler
-
批准号:7794037
-
项目类别:
-
资助金额:$20.14万
-
财政年份:2010
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC DETERMINANTS OF ORTHOSTATIC TOLERANCE
-
批准号:8147945
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2010
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8136818
-
项目类别:
-
资助金额:$13.95万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7680534
-
项目类别:
-
资助金额:$125.95万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
training - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7901217
-
项目类别:
-
资助金额:$7.81万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8327851
-
项目类别:
-
资助金额:$121.56万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8150403
-
项目类别:
-
资助金额:$122.62万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8765054
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:9146407
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
NATURAL HISTORY STUDY
-
批准号:8932316
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Administrative unit - Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7901219
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:7925727
-
项目类别:
-
资助金额:$122.15万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Rare Diseases Clinical Research Consortium
-
批准号:8538516
-
项目类别:
-
资助金额:$121.73万
-
财政年份:2009
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Administrative Core
-
批准号:7252848
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
Autonomic Determinants of Orthostatic Tolerance
-
批准号:7252842
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2007
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
THE GENETIC BASIS OF AUTONOMIC DYSFUNCTION
-
批准号:7605552
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC SCREENING
-
批准号:7605565
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
THE GENETIC BASIS OF AUTONOMIC DYSFUNCTION
-
批准号:7731377
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
AUTONOMIC SCREENING
-
批准号:7731390
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2006
-
负责人:DAVID HERLIE ROBERTSON
-
依托单位:
海外基金